These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10367954)

  • 1. Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine.
    Brunel F; Darbouret A; Ronco J
    Vaccine; 1999 Apr; 17(17):2192-203. PubMed ID: 10367954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
    Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RLJ-NE-299A: a new plant based vaccine adjuvant.
    Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
    Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
    Xie Y; Sun HX; Li D
    Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.
    Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR
    J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
    Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
    FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars.
    Tonnis WF; Amorij JP; Vreeman MA; Frijlink HW; Kersten GF; Hinrichs WL
    Eur J Pharm Sci; 2014 May; 55():36-45. PubMed ID: 24468629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine.
    Hjertner B; Bengtsson T; Morein B; Paulie S; Fossum C
    Vaccine; 2018 May; 36(23):3340-3344. PubMed ID: 29706292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
    J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
    Khajuria A; Gupta A; Malik F; Singh S; Singh J; Gupta BD; Suri KA; Suden P; Srinivas VK; Ella K; Qazi GN
    Vaccine; 2007 Jun; 25(23):4586-94. PubMed ID: 17498851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.
    McCluskie MJ; Davis HL
    J Immunol; 1998 Nov; 161(9):4463-6. PubMed ID: 9794366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.
    Tada R; Hidaka A; Iwase N; Takahashi S; Yamakita Y; Iwata T; Muto S; Sato E; Takayama N; Honjo E; Kiyono H; Kunisawa J; Aramaki Y
    PLoS One; 2015; 10(10):e0139785. PubMed ID: 26440657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate.
    Wang S; Liu X; Fisher K; Smith JG; Chen F; Tobery TW; Ulmer JB; Evans RK; Caulfield MJ
    Vaccine; 2000 Jan; 18(13):1227-35. PubMed ID: 10649624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.
    Schirmbeck R; Reimann J
    Intervirology; 2001; 44(2-3):115-23. PubMed ID: 11509872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model.
    Zheng B; Woo PC; Ng M; Tsoi H; Wong L; Yuen K
    Vaccine; 2001 Oct; 20(1-2):140-7. PubMed ID: 11567758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response.
    Kwissa M; Lindblad EB; Schirmbeck R; Reimann J
    J Mol Med (Berl); 2003 Aug; 81(8):502-10. PubMed ID: 12879151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
    Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
    Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.